Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'MORPHINE-WITHDRAWAL' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 224 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Diaz, SL; Kemmling, AK; Rubio, MC; Balerio, GN
      Lack of sex-related differences in the prevention by baclofen of the morphine withdrawal syndrome in mice

      BEHAVIOURAL PHARMACOLOGY
    2. Dehpour, AR; Samini, M; Arad, MA; Namiranian, K
      Clonidine attenuates naloxone-induced opioid-withdrawal syndrome in cholestatic mice

      PHARMACOLOGY & TOXICOLOGY
    3. Clausen, TR; Moller, M; Woldbye, DPD
      Inhibitory effect of neuropeptide Y on morphine withdrawal is accompanied by reduced c-fos expression in specific brain regions

      JOURNAL OF NEUROSCIENCE RESEARCH
    4. Skoubis, PD; Matthes, HW; Walwyn, WM; Kieffer, BL; Maidment, NT
      Naloxone fails to produce conditioned place aversion in mu-opioid receptorknock-out mice

      NEUROSCIENCE
    5. Tokuyama, S; Zhu, H; Oh, S; Ho, IK; Yamamoto, T
      Further evidence for a role of NMDA receptors in the locus coeruleus in the expression of withdrawal syndrome from opioids

      NEUROCHEMISTRY INTERNATIONAL
    6. Britton, KT; Southerland, S
      Naloxone blocks 'anxiolytic' effects of neuropeptide Y

      PEPTIDES
    7. Schrott, LM; Sparber, SB
      Embryonic 'binge' cocaine exposure alters neural-immune and neural-endocrine interactions in young chickens: involvement of serotonin(2) receptors

      DEVELOPMENTAL BRAIN RESEARCH
    8. Lichtman, AH; Fisher, J; Martin, BR
      Precipitated cannabinoid withdrawal is reversed by Delta(9)-tetrahydrocannabinol or clonidine

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    9. Kotlinska, J
      Attenuation of morphine dependence and withdrawal by glycine(B) site antagonists in rats

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    10. Milanes, MV; Martinez, MD; Gonzalez-Cuello, A; Laorden, ML
      Evidence for a peripheral mechanism in cardiac opioid withdrawal

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    11. Martinez, PJ; Laorden, ML; Cerezo, M; Martinez-Pinero, MG; Milanes, MV
      Characterization of the signal transduction pathways mediating morphine withdrawal-stimulated c-fos expression in hypothalamic nuclei

      EUROPEAN JOURNAL OF PHARMACOLOGY
    12. Milanes, MV; Marin, MT; Laorden, ML
      Effects of morphine withdrawal on catecholaminergic neurons on heart rightventricle; implication of dopamine receptors

      CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
    13. Chieng, B; Bekkers, JM
      Inhibition of calcium channels by opioid- and adenosine-receptor agonists in neurons of the nucleus accumbens

      BRITISH JOURNAL OF PHARMACOLOGY
    14. Morales, L; Perez-Garcia, C; Alguacil, LF
      Effects of yohimbine on the antinociceptive and place conditioning effectsof opioid agonists in rodents

      BRITISH JOURNAL OF PHARMACOLOGY
    15. Doi, N; Brown, CH; Cohen, HD; Leng, G; Russell, JA
      Effects of the endogenous opioid peptide, endomorphin 1, on supraoptic nucleus oxytocin and vasopressin neurones in vivo and in vitro

      BRITISH JOURNAL OF PHARMACOLOGY
    16. Mihaly, E; Legradi, G; Fekete, C; Lechan, RA
      Efferent projections of ProTRH neurons in the ventrolateral periaqueductalgray

      BRAIN RESEARCH
    17. Dawe, GS; Huff, KD; Vandergriff, JL; Sharp, T; O'Neill, MJ; Rasmussen, K
      Olanzapine activates the rat locus coeruleus: In vivo electrophysiology and c-fos immunoreactivity

      BIOLOGICAL PSYCHIATRY
    18. Zhu, HB; Barr, GA
      Opiate withdrawal during development: are NMDA receptors indispensable?

      TRENDS IN PHARMACOLOGICAL SCIENCES
    19. Gobbi, G; Muntoni, AL; Gessa, GL; Diana, M
      Clonidine fails to modify dopaminergic neuronal activity during morphine withdrawal

      PSYCHOPHARMACOLOGY
    20. Bisaga, A; Comer, SD; Ward, AS; Popik, P; Kleber, HD; Fischman, MW
      The NMDA antagonist memantine attenuates the expression of opioid physicaldependence in humans

      PSYCHOPHARMACOLOGY
    21. McNally, GP; Akil, H
      Effects of contextual or olfactory cues previously paired with morphine withdrawal on behavior and pain sensitivity in the rat

      PSYCHOPHARMACOLOGY
    22. Spielewoy, C; Gonon, F; Roubert, C; Fauchey, V; Jaber, M; Caron, MG; Roques, BP; Hamon, M; Betancur, C; Maldonado, R; Giros, B
      Increased rewarding properties of morphine in dopamine-transporter knockout mice

      EUROPEAN JOURNAL OF NEUROSCIENCE
    23. Lu, L; Liu, DH; Ceng, XB; Ma, L
      Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence

      EUROPEAN JOURNAL OF NEUROSCIENCE
    24. Capasso, A; De Tommasi, N; Rastrelli, L; De Simone, F
      New protopine alkaloids from Aristolochia constricta reduce morphine withdrawal in vitro

      PHYTOTHERAPY RESEARCH
    25. Walters, CL; Aston-Jones, G; Druhan, JP
      Expression of Fos-related antigens in the nucleus accumbens during opiate withdrawal and their attenuation by a D2 dopamine receptor agonist

      NEUROPSYCHOPHARMACOLOGY
    26. Panagis, G; Hildebrand, BE; Svensson, TH; Nomikos, GG
      Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome

      SYNAPSE
    27. Dehpour, AR; Sadeghipour, HR; Nowroozi, A; Akbarloo, N
      The effect of the serotonergic system on opioid withdrawal-like syndrome in a mouse model of cholestasis

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    28. Dehpour, AR; Samini, M; Rastegar, H; Ardeshiri, AJ; Roushanzamir, F; Jorjani, M; Ahmadiani, A
      Effect of NMDA receptor antagonist on naloxone-precipitated withdrawal signs in cholestatic mice

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    29. Samini, M; Fakhrian, R; Mohagheghi, M; Dehpour, AR
      Comparison of the effect of levodopa and bromocriptine on naloxone-precipitated morphine withdrawal symptoms in mice

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    30. Felip, CM; Rodriguez-Arias, M; Espejo, EF; Minarro, J; Stinus, L
      Naloxone-induced opiate withdrawal produces long-lasting and context-independent changes in aggressive and social behaviors of postdependent male mice

      BEHAVIORAL NEUROSCIENCE
    31. Bisaga, A; Popik, P
      In search of a new pharmacological treatment for drug and alcohol addiction: N-methyl-D-aspartate (NMDA) antagonists

      DRUG AND ALCOHOL DEPENDENCE
    32. Diaz, A; Florez, J; Pazos, A; Hurle, MA
      Opioid tolerance and supersensitivity induce regional changes in the autoradiographic density of dihydropyridine-sensitive calcium channels in the rat central nervous system

      PAIN
    33. Cui, CL; Wu, LZ; Han, JS
      Spinal kappa-opioid system plays an important role in suppressing morphinewithdrawal syndrome in the rat

      NEUROSCIENCE LETTERS
    34. Brown, CH; Russell, JA; Leng, G
      Opioid modulation of magnocellular neurosecretory cell activity

      NEUROSCIENCE RESEARCH
    35. Jones, KL; Barr, GA
      Opiate withdrawal in the fetal rat: A behavioral profile

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    36. Christensen, D; Guilbaud, G; Kayser, V
      The effect of the glycine/NMDA receptor antagonist, (+)-HA966, on morphinedependence in neuropathic rats

      NEUROPHARMACOLOGY
    37. Diaz, A; Pazos, A; Florez, J; Hurle, MA
      Autoradiographic mapping of mu-opioid receptors during opiate tolerance and supersensitivity in the rat central nervous system

      NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
    38. Laorden, ML; Milanes, MV
      Effects of U-50,488H and U-50,488H withdrawal on catecholaminergic neuronsof the rat hypothalamus

      LIFE SCIENCES
    39. Kotlinska, J; Suder, P; Legowska, A; Rolka, K; Silberring, J
      Orphanin FQ/nociceptin inhibits morphine withdrawal

      LIFE SCIENCES
    40. Rubino, T; Massi, P; Vigano, D; Fuzio, D; Parolaro, D
      Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome

      LIFE SCIENCES
    41. Druhan, JP; Walters, CL; Aston-Jones, G
      Behavioral activation induced by D-2-like receptor stimulation during opiate withdrawal

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    42. Neugebauer, V; Zinebi, F; Russell, R; Gallagher, JP; Shinnick-Gallagher, P
      Cocaine and kindling alter the sensitivity of group II and III metabotropic glutamate receptors in the central amygdala

      JOURNAL OF NEUROPHYSIOLOGY
    43. Iredale, PA; Alvaro, JD; Lee, Y; Terwilliger, R; Chen, YL; Duman, RS
      Role of corticotropin-releasing factor receptor-1 in opiate withdrawal

      JOURNAL OF NEUROCHEMISTRY
    44. Fukunaga, Y; Kishioka, S
      Enkephalinergic neurons in the periaqueductal gray and morphine withdrawal

      JAPANESE JOURNAL OF PHARMACOLOGY
    45. Milanes, MV; Laorden, ML
      Changes in catecholaminergic pathways innervating the rat heart ventricle during morphine dependence. Involvement of alpha(1)- and alpha(2)-adrenoceptors

      EUROPEAN JOURNAL OF PHARMACOLOGY
    46. Nakagawa, T; Masuda, T; Watanabe, T; Minami, M; Satoh, M
      Possible involvement of the locus coeruleus in inhibition by prostanoid EP3 receptor-selective agonists of morphine withdrawal syndrome in rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    47. Subhan, F; Pache, DM; Sewell, RDE
      Potentiation of opioid-induced conditioned place preference by the selective serotonin reuptake inhibitor fluoxetine

      EUROPEAN JOURNAL OF PHARMACOLOGY
    48. Sullivan, ME; Hall, SR; Milne, B; Jhamandas, K
      Suppression of acute and chronic opioid withdrawal by a selective soluble guanylyl cyclase inhibitor

      BRAIN RESEARCH
    49. Shippenberg, TS; Funada, M; Schutz, CG
      Dynorphin A (2-17) attenuates the unconditioned but not the conditioned effects of opiate withdrawal in the rat

      PSYCHOPHARMACOLOGY
    50. Stinus, L; Caille, S; Koob, GF
      Opiate withdrawal-induced place aversion lasts for up to 16 weeks

      PSYCHOPHARMACOLOGY
    51. Cuellar, B; Fernandez, AP; Lizasoain, I; Moro, MA; Lorenzo, P; Bentura, ML; Rodrigo, J; Leza, JC
      Up-regulation of neuronal NO synthase immunoreactivity in opiate dependence and withdrawal

      PSYCHOPHARMACOLOGY
    52. Alper, KR; Lotsof, HS; Frenken, GMN; Luciano, DJ; Bastiaans, J
      Treatment of acute opioid withdrawal with ibogaine

      AMERICAN JOURNAL ON ADDICTIONS
    53. Suzuki, T; Tomono, K; Hanano, M
      Effect of the opioid antagonist naloxone on the regional metabolic rate for glucose in the conscious rat brain

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    54. Hildebrand, BE; Panagis, G; Svensson, TH; Nomikos, GG
      Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat: Role of nicotinic receptors in the ventral tegmental area

      NEUROPSYCHOPHARMACOLOGY
    55. Cutler, DJ; Mundey, MK; Mason, R
      Electrophysiological effects of opioid receptor activation on Syrian hamster suprachiasmatic nucleus neurones in vitro

      BRAIN RESEARCH BULLETIN
    56. Yip, J; Chahl, LA
      Distribution of Fos-like immunoreactivity in guinea-pig brain following administration of the neurokinin-1 receptor agonist, [Sar(9),Met(O-2)(11)]substance P

      NEUROSCIENCE
    57. Leng, G; Brown, CH; Russell, JA
      Physiological pathways regulating the activity of magnocellular neurosecretory cells

      PROGRESS IN NEUROBIOLOGY
    58. Manzoni, OJ; Williams, JT
      Presynaptic regulation of glutamate release in the ventral tegmental area during morphine withdrawal

      JOURNAL OF NEUROSCIENCE
    59. Schreiber, S; Getslev, V; Backer, MM; Weizman, R; Pick, CG
      The atypical neuroleptics clozapine and olanzapine differ regarding their antinociceptive mechanisms and potency

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    60. Schrott, LM; Sweeney, WA; Bodensteiner, KE; Sparber, SB
      Late embryonic ritanserin exposure fails to alter normal responses to immune system stimulation in young chicks

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    61. Rodriguez-Arias, M; Pinazo, J; Minarro, J; Stinus, L
      Effects of SCH 23390, raclopride, and haloperidol on morphine withdrawal-induced aggression in male mice

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    62. Ballard, TM; McAllister, KH
      Acutely administered clozapine does not modify naloxone-induced withdrawaljumping in morphine-dependent mice

      PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR
    63. Klodzinska, A; Chojnacka-Wojcik, E; Palucha, A; Branski, P; Popik, P; Pilc, A
      Potential anti-anxiety, anti-addictive effects of LY 354740, a selective group II glutamate metabotropic receptors agonist in animal models

      NEUROPHARMACOLOGY
    64. Caille, S; Espejo, EF; Reneric, JP; Cador, M; Koob, GF; Stinus, L
      Total neurochemical lesion of noradrenergic neurons of the locus ceruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    65. Ohsawa, M; Kamei, J
      Modification of the expression of naloxone-precipitated withdrawal signs in morphine-dependent mice by diabetes: Possible involvement of protein kinase C

      JAPANESE JOURNAL OF PHARMACOLOGY
    66. Medvedev, IO; Dravolina, OA; Bespalov, AY
      Differential effects of nitric oxide synthase inhibitor, 7-nitroindazole, on discriminative stimulus and somatic effects of naloxone in morphine-dependent rats

      EUROPEAN JOURNAL OF PHARMACOLOGY
    67. Cappendijk, SLT; Hurd, YL; Nylander, I; van Ree, JM; Terenius, L
      A heroin-, but not a cocaine-expecting, self-administration state preferentially alters endogenous brain peptides

      EUROPEAN JOURNAL OF PHARMACOLOGY
    68. Airio, J; Ahtee, L
      The involvement of noradrenergic transmission in the morphine-induced locomotor hyperactivity in mice withdrawn from repeated morphine treatment

      BRITISH JOURNAL OF PHARMACOLOGY
    69. Wu, LZ; Cui, CL; Tian, JB; Ji, D; Han, JS
      Suppression of morphine withdrawal by electroacupuncture in rats: dynorphin and kappa-opioid receptor implicated

      BRAIN RESEARCH
    70. Lacerra, C; Martijena, ID; Bustos, SG; Molina, VA
      Benzodiazepine withdrawal facilitates the subsequent onset of escape failures and anhedonia: influence of different antidepressant drugs

      BRAIN RESEARCH
    71. Ohsawa, M; Kamei, J
      Role of intracellular calcium on the modulation of naloxone-precipitated withdrawal jumping in morphine-dependent mice by diabetes

      BRAIN RESEARCH
    72. Rosen, MI; Kosten, TR; Kreek, MJ
      The effects of naltrexone maintenance on the response to yohimbine in healthy volunteers

      BIOLOGICAL PSYCHIATRY
    73. Carrera, MRA; Schulteis, G; Koob, GF
      Heroin self-administration in dependent Wistar rats: increased sensitivityto naloxone

      PSYCHOPHARMACOLOGY
    74. TOKUYAMA S; ZHU H; WAKABAYASHI H; FENG YZ; HO IK
      THE ROLE OF GLUTAMATE IN THE LOCUS-COERULEUS DURING OPIOID WITHDRAWALAND EFFECTS OF H-7, A PROTEIN-KINASE INHIBITOR, ON THE ACTION OF GLUTAMATE IN RATS

      Journal of biomedical science
    75. GHELARDINI C; GALEOTTI N; DONALDSON S; BARTOLINI A
      THE ANTIMIGRAINE DRUG ERGOTAMINE IS ENDOWED WITH ANTIHYPERALGESIC ACTIVITY

      PTR. Phytotherapy research
    76. SCHULTEIS G; STINUS L; RISBROUGH VB; KOOB GF
      CLONIDINE BLOCKS ACQUISITION BUT NOT EXPRESSION OF CONDITIONED OPIATEWITHDRAWAL IN RATS

      Neuropsychopharmacology
    77. ADAMS ML; CICERO TJ
      ALCOHOL-INTOXICATION AND WITHDRAWAL - THE ROLE OF NITRIC-OXIDE

      Alcohol
    78. Merchenthaler, I; Funkhouser, JM; Carver, JM; Lundeen, SG; Ghosh, K; Winneker, RC
      The effect of estrogens and antiestrogens in a rat model for hot flush

      MATURITAS
    79. PINELLI A; TRIVULZIO S; SPEZIA R
      EFFECTS OF TIZANIDINE ADMINISTRATION ON PRECIPITATED OPIOID WITHDRAWAL SIGNS IN RATS

      Drug and alcohol dependence
    80. BELLCHAMBERS CE; CHIENG B; KEAY KA; CHRISTIE MJ
      SWIM-STRESS BUT NOT OPIOID WITHDRAWAL INCREASES EXPRESSION OF C-FOS IMMUNOREACTIVITY IN RAT PERIAQUEDUCTAL GRAY NEURONS WHICH PROJECT TO THE ROSTRAL VENTROMEDIAL MEDULLA

      Neuroscience
    81. BRUGGER S; SANCHEZ R; BRUGGER AJ; MARTINEZ JA
      ICV ADMINISTRATION OF CRF BLOCKER (CRF9-41-DELTA HELICAL) REDUCES MORPHINE-WITHDRAWAL IN RATS

      Progress in neuro-psychopharmacology & biological psychiatry
    82. ROHDE DS; BASBAUM AI
      ACTIVATION OF COERULEOSPINAL NORADRENERGIC INHIBITORY CONTROLS DURINGWITHDRAWAL FROM MORPHINE IN THE RAT

      The Journal of neuroscience
    83. FUKUNAGA Y; NISHIDA S; INOUE N; MIYAMOTO M; KISHIOKA S; YAMAMOTO H
      TIME-COURSE OF MORPHINE-WITHDRAWAL AND PREPROENKEPHALIN GENE-EXPRESSION IN THE PERIAQUEDUCTAL GRAY OF RATS

      Molecular brain research
    84. GRUBB MC; STORNETTA RL; PENCE R; BAERTSCHI AJ; GUYENET PG
      ANTAGONIST PRECIPITATED CLONIDINE WITHDRAWAL IN RAT - EFFECTS ON LOCUS-COERULEUS NEURONS, SYMPATHETIC-NERVES AND CARDIOVASCULAR PARAMETERS

      Journal of the autonomic nervous system
    85. BOLLWEG G; SPARBER SB
      RELATIONSHIPS BETWEEN MIDEMBRYONIC 5-HT2 AGONIST AND OR ANTAGONIST EXPOSURE AND DETOUR LEARNING BY CHICKENS/

      Pharmacology, biochemistry and behavior
    86. STINUS L; ROBERT C; KARASINSKI P; LIMOGE A
      CONTINUOUS QUANTITATIVE MONITORING OF SPONTANEOUS OPIATE WITHDRAWAL -LOCOMOTOR-ACTIVITY AND SLEEP DISORDERS

      Pharmacology, biochemistry and behavior
    87. GRASING K; GHOSH S
      SELEGILINE PREVENTS LONG-TERM CHANGES IN DOPAMINE EFFLUX AND STRESS IMMOBILITY DURING THE 2ND AND 3RD WEEKS OF ABSTINENCE FOLLOWING OPIATE WITHDRAWAL

      Neuropharmacology
    88. POPIK P; MAMCZARZ J; FRACZEK M; WIDLA M; HESSELINK M; DANYSZ W
      INHIBITION OF REINFORCING EFFECTS OF MORPHINE AND NALOXONE-PRECIPITATED OPIOID WITHDRAWAL BY NOVEL GLYCINE SITE AND UNCOMPETITIVE NMDA RECEPTOR ANTAGONISTS

      Neuropharmacology
    89. CARON RW; LENG G; LUDWIG M; RUSSELL JA
      NALOXONE-INDUCED SUPERSENSITIVITY OF OXYTOCIN NEURONS TO OPIOID ANTAGONISTS

      Neuropharmacology
    90. KAYSER V; IDANPAANHEKKILA JJ; CHRISTENSEN D; GUILBAUD G
      THE SELECTIVE CHOLECYSTOKTIN(B) RECEPTOR ANTAGONIST L-365,260 DIMINISHES THE EXPRESSION OF NALOXONE-INDUCED MORPHINE-WITHDRAWAL SYMPTOMS INNORMAL AND NEUROPATHIC RATS

      Life sciences
    91. KATSURA M; HARA A; HIGO A; TARUMI C; HIBINO Y; OHKUMA S
      CONTINUOUS TREATMENT WITH MORPHINE INCREASES DIAZEPAM-BINDING INHIBITOR MESSENGER-RNA IN MOUSE-BRAIN

      Journal of neurochemistry
    92. ZHU H; ROCKHOLD RW; HO IK
      THE ROLE OF GLUTAMATE IN PHYSICAL-DEPENDENCE ON OPIOIDS

      Japanese Journal of Pharmacology
    93. Fukunaga, Y; Inoue, N; Miyamoto, M; Kishioka, S; Yamamoto, H
      Effects of peptidase inhibitors, D-Ala(2), Met(5)-enkephalinamide and antiserum to methionine-enkephalin microinjected into the caudal periaqueductal gray on morphine withdrawal in rats

      JAPANESE JOURNAL OF PHARMACOLOGY
    94. Kimes, AS; Maldonado, R; Ambrosio, E; Koob, GF; London, ED
      Cerebral glucose metabolism during opioid withdrawal following methylnaloxonium injection into the locus coeruleus

      BRAIN RESEARCH
    95. TAYLOR JR; PUNCH LJ; ELSWORTH JD
      A COMPARISON OF THE EFFECTS OF CLONIDINE AND CNQX INFUSION INTO THE LOCUS-COERULEUS AND THE AMYGDALA ON NALOXONE-PRECIPITATED OPIATE WITHDRAWAL IN THE RAT

      Psychopharmacology
    96. ERNST M; LONDON ED
      BRAIN IMAGING STUDIES OF DRUG-ABUSE - THERAPEUTIC IMPLICATIONS

      Seminars in the neurosciences
    97. WILLIAMS RL; AKUNNE HC; NONAVINAKERE VK; SOLIMAN KFA
      CHRONOMODULATION OF WITHDRAWAL SIGNS IN MORPHINE-DEPENDENT RATS

      Biological rhythm research
    98. WANG GJ; VOLKOW ND; FOWLER JS; LOGAN J; ABUMRAD NN; HITZEMANN RJ; PAPPAS NS; PASCANI K
      DOPAMINE D-2 RECEPTOR AVAILABILITY IN OPIATE-DEPENDENT SUBJECTS BEFORE AND AFTER NALOXONE-PRECIPITATED WITHDRAWAL

      Neuropsychopharmacology
    99. LIN SK; STRANG J; SU LW; TSAI CJ; HU WH
      DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL OF LOFEXIDINE VERSUS CLONIDINE IN THE TREATMENT OF HEROIN WITHDRAWAL

      Drug and alcohol dependence
    100. KOMBIAN SB; SALEH TM; FIAGBE NIY; CHEN XH; AKABUTU JJ; BUOLAMWINI JK; PITTMAN QJ
      IBOGAINE AND A TOTAL ALKALOIDAL EXTRACT OF VOACANGA-AFRICANA MODULATENEURONAL EXCITABILITY AND SYNAPTIC TRANSMISSION IN THE RAT PARABRACHIAL NUCLEUS IN-VITRO

      Brain research bulletin


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 01/06/20 alle ore 08:23:04